Question 1

What is the catalog number for FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human) is 19913121.

Question 2

What sizes are available for FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Question 5

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 6

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

FAM19A2 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Lung Specific Antigen (LSA120), 0.2mg/mL

CD106 / VCAM1 (B-K9), 0.2mg/mL

Bcl-2 (8C8), CF405M conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF647 conjugate, 0.1mg/mL

GFAP (GA-5), Biotin conjugate, 0.1mg/mL

Desmoglein-3 (Squamous Cell Marker) (DSG3/2840), CF647 conjugate, 0.1mg/mL